Dates:
Part 1: Harm Reduction for Health Care; May 5th at 11:00 PM – 12:00 PM CST
Part 2: Buprenorphine in New York State: A Clinical Overview; May 19th at 11:00 PM – 12:00 PM CST
Click here to Register for Part 1.
Click here to Register for Part 2.
HRSA Region 2 & the Hepatitis C and Drug User Health Center Excellence Presents a Two- Part Series on Substance Use Disorder
The Health Resources and Services Administration (HRSA) Region 2 is inviting you to a two-part webinar series on Substance Use Disorder, in collaboration with the Mount Sinai Hepatitis C and Drug User Health Center Excellence. This two course series aims to increase medical providers’ capacity to care for people who use drugs, and in particular individuals with opioid use disorder. In part 1 of the series, the discussion will focus on the importance of having a harm reduction approach to medical care in order to decrease overdose risk, transmission of blood borne viruses, and other negative health outcomes associated with substance use. In part 2 of the series, the discussion will focus on buprenorphine treatment for opioid use disorder and identify how it fits within a harm reduction framework. Additionally, it will review federal and state requirements for prescribing buprenorphine, discuss perceived challenges regarding implementing buprenorphine and review strategies to overcome said challenges.